To get more information on CBD Nutraceuticals Market - Request Free Sample Report
The CBD Nutraceuticals Market was valued at USD 9.75 billion in 2023 and is expected to reach USD 39.06 billion by 2032, growing at a CAGR of 16.38% from 2024-2032.
CBD nutraceuticals are witnessing robust growth, supported by the increasing consumer demand for natural health solutions and the progressive legalization of cannabidiol-based products. As the potential therapeutic benefits of hemp (e.g., to mitigate anxiety, pain, and sleep issues) come into focus, CBD nutraceuticals — which range from tinctures to capsules, from edibles to powders — are becoming increasingly popular as alternatives to synthetic supplements. This growing demand is also accelerated by increasing awareness among millennial and Gen Z populations of wellness trends and preventive healthcare.
The market has significantly improved due to recent regulatory breakthroughs. The legalization of CBD derived from hemp led to wide availability in areas including North America, selected European countries, and other developing economies such as Latin America. A classic example is the U.S. Farm Bill 2018, which facilitated broad commercial success for CBD products as hemp cultivation is now permitted and hemp-derived CBD has been expunged from the Controlled Substances Act. In 2022, 26% of American adults used CBD, a significant increase from 6% in 2018. The percentage of CBD users in the U.S. rise to 35% in 2024. The legal clarity on this aspect has spurred product innovation and investments by large nutraceutical and wellness companies.
Market growth is further driven by the diversification of products. There are emerging product innovations, such as CBD-infused beverages, gummies, and skincare products, as companies respond to evolving consumer preferences. Vena CBD, for instance, recently rolled out a skincare line infused with the relaxation compound because it has anti-inflammatory and moisturizing properties. In this regard, CBD is being incorporated into wider health and beauty genres.
Drivers
Increased consumer awareness of the need for natural wellness solutions propels CBD Nutraceuticals Market growth.
Modern consumers are increasingly relying on natural, plant-based ingredients to support their health and wellness goals. CBD nutraceuticals, sourced from hemp or cannabis, are perceived as effective non-addictive solutions addressing chronic pain, anxiety, sleep disorders, and inflammation-related issues. This trend follows an ever-increasing appreciation for CBD's potential medicinal applications supported by emerging research and influencers in wellness circles.
Another reason is the increasing demand for preventive health care around the world, which calls for functional foods and supplements that can enhance long-term wellness. CBD-infused nutraceuticals perfectly fit the bill as they deliver functional benefits through natural sources. It is highly pronounced among millennials and Gen Z consumers who believe in holistic health and are always on the lookout for novel health products. The increasing availability of education and marketing campaigns about the advantages of CBD has increased its appeal to various segments of the market.
Increasing Legalization and Regulatory Support for CBD Products
Recent years have seen a great deal of the regulatory landscape shift in favor of CBD. Countries as big as the United States and Canada have removed restrictions on CBD coming from industrial hemp, as long as it contains less than 0.3% THC. According to a report by Forbes Health, as of 2023, CBD consumption is either fully legal or conditionally permitted in all 50 states in the U.S. This has made the market for CBD-based nutraceuticals go through the roof. The U.S. Farm Bill was passed back in 2018, making it legal to derive CBD from hemp. This opened doors for mass production and commercialization of CBD products.
It will encourage more established pharmaceutical, nutraceutical, and FMCG companies to come into the market for the development of better-quality products. Moreover, increased governmental supervision also increased consumer confidence in CBD product safety and efficacy. Regulations are advancing in regions such as Latin America and Asia-Pacific, and new opportunities are emerging there. Brazil and Australia have started incorporating policies that support CBD; in turn, it is accelerating growth prospects.
These legal shifts not only allow for market growth but also encourage research and innovation, allowing companies to develop more diverse product offerings, such as CBD-infused beverages, capsules, gummies, and powders that are tailored to specific health needs.
Restraint
The advancement in the legalization of CBD products, this market remains extremely challenging due to the inconstant and very complex regulatory frameworks across the various regions.
Some countries and states have legalized CBD for its application on the medical and wellness side while others impose strict restrictions or even ban it. The variations in the THC threshold level, the labeling requirements, and the classifications of products make compliance an issue for manufacturers and distributors who are operating in various markets.
Regulatory ambiguity or unhelpful laws prevail in places like Asia and the Middle East. In more mature markets in the U.S. and Europe, regulatory confusion—such as whether CBD will be considered a food additive or a dietary supplement—continues to impede product approvals and entries into these markets. In general, there is no widespread quality control and testing regimen, leading to consumer concerns that may have a dampening effect on overall adoption rates.
By Product
CBD tinctures segment dominated the market with a market share of 40% in 2023. The products helped in dealing with several medical conditions like chronic pain, depression, substance use disorders, and cancer-related symptoms and could be easily accessed. A few of the most influential brands in this industry, such as Charlotte's Web, Inc. and Elixinol, have successfully launched different types of CBD oils for human as well as animal health. For instance, Charlotte's Web provides a pet product with 17 mg of plant-based cannabinoids per 1 ml in an unflavored and chicken-flavored variant. Owing to the ease of access via online shopping and increasing market penetration, this segment is likely to continue growth in the coming years.
The capsules and soft gels segment is expected to grow at the fastest CAGR throughout the forecast period. This growth is fueled by a rising prevalence of health issues, an increased focus on health and nutrition, and the convenience these products offer. More consumer trust is being experienced with capsules and soft gels as compared to CBD gummies. The rising demand for supplements that not only enhance overall wellness but also comfort has increased their consumption. Moreover, the various products containing additional ingredients, such as reishi mushroom, ginseng root, and ginkgo leaf extracts, have significantly increased the demand in this category.
By Distribution Channel
In 2023, the retail store's segment dominated the market for the largest market share with 42%. Multiple factors, such as enhanced accessibility, the availability of a wide range of products from various facilities, and moves by top companies to improve brand visibility through offline marketing, will continue to drive the market. Leading manufacturers enable a comprehensive appearance through retail channels including superstores, pharmacies, down markets, and recreational and healthcare retail outlets. Further, the market on the provision of CBD products such as beverages in restaurants and coffee shop outlets helps to maintain the expansion of the market.
The online segment is expected to expand at the fastest CAGR throughout the forecast period. Expanding internet purchasing and marketing channels, an expanded offering of CBD products through e-commerce platforms, and suppliers’ and companies’ e-commerce e-store establishment will drive demand. Facilitated by value-added offerings including doorstep delivery, specialist advice, product expertise, customer feedback, item summaries, and adaptable return and refund conditions, consumers regularly select internet purchasing.
In 2023, North America dominated the market accounted for a market share of 50%, and led the CBD nutraceuticals market. Factors such as increasing consumer awareness, wide use of CBD in various applications, and the favorable regulatory scenario in countries such as the U.S. and Canada were responsible for this regional market share. Furthermore, North America’s well-developed healthcare infrastructure and research and development center focusing on CBD use in foods, cosmetics, and medicine have boosted the market in recent years.
Asia Pacific will have the fastest compound annual growth rate of 18.48% during the forecast period. Factors like the potential for CBD legalization, growing acceptance of CBD for medicinal use, rising incidence of chronic and non-communicable conditions, and cultural awareness in nations such as India, where cannabis is revered, are the main drivers for this market. The expansion of CBD-based healthcare sectors and increased disposable income are two factors that contribute to the large market share. Increased disposable income is leading the way to increased consumer spending on health and wellness products in the world’s second-largest economy. Demand for CBD nutraceuticals has increased as senior health solutions become more popular.
Get Customized Report as per Your Business Requirement - Enquiry Now
Charlotte's Web (CBD Oil Tinctures, CBD Gummies)
CV Sciences (PlusCBD Oil Softgels, PlusCBD Oil Balm)
Elixinol (Elixinol Hemp Oil Capsules, Elixinol CBD Oil Tincture)
Green Roads (CBD Oil 100mg-1500mg, CBD Relax Bears)
Medterra (Medterra CBD Gel Capsules, Medterra CBD Oil Tincture)
PureKana (PureKana CBD Oil Tincture, PureKana CBD Capsules)
HempFusion (HempFusion Full Spectrum Hemp Extract Softgels,
HempFusion CBD Gummies)
Lazarus Naturals (Lazarus CBD Oil Tinctures, Lazarus CBD Softgels)
Joy Organics (Joy Organics CBD Softgels, Joy Organics CBD Oil Tinctures)
FAB CBD (FAB CBD Oil Tinctures, FAB CBD Gummies)
Sunday Scaries (Sunday Scaries CBD Gummies, Sunday Scaries CBD Oil
Tincture)
CBDFx (CBD Gummies with Turmeric and Spirulina, CBD Vape Pens)
Koi CBD (Koi CBD Gummies, Koi CBD Tinctures)
cbdMD (cbdMD CBD Oil Tinctures, cbdMD CBD Gummies)
Green Gorilla (Organic CBD Oil Drops, CBD Capsules)
NuLeaf Naturals (NuLeaf CBD Oil, NuLeaf CBD Softgels)
Serenity CBD (Serenity CBD Capsules, Serenity CBD Oil)
Vitality CBD (Vitality CBD Gummies, Vitality CBD Capsules)
The CBDistillery (CBD Oil Tincture, CBD Isolate Powder)
American Shaman (CBD Oil Tincture, CBD Topicals)
Key suppliers
These suppliers provide the essential raw materials, CBD extracts, isolates, and distillates needed for creating various CBD-based nutraceutical products.
HempMeds Suppliers
CW Hemp (Charlotte’s Web) Suppliers
Kenevir Suppliers
Cannabis Sativa, Inc. Suppliers
Elixinol Suppliers
Green Organic Dutchman (TGOD) Suppliers
Purisys Suppliers
HempLife Today Suppliers
Biomass Processing Solutions (BPS) Supplier
Nutraceutical Corporation Suppliers
In May 2024, CV Sciences Inc. acquired Elevated Softgels LLC, a prominent player in the encapsulated softgels and tinctures market. This acquisition enhances CV Sciences' global presence and solidifies its position in the CBD nutraceuticals industry.
In November 2023, Charlotte's Web expanded its ReCreate brand by introducing a new line of CBD gummies formulated with functional botanicals, specifically targeting the sports and wellness sector. The newly launched products include endurance gummies, muscle recovery gummies, brain support gummies, and rest gummies.
Report Attributes | Details |
---|---|
Market Size in 2023 | US$ 9.75 Billion |
Market Size by 2032 | US$ 39.06 Billion |
CAGR | CAGR of 16.38% From 2024 to 2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Data | 2020-2022 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
Key Segments | • By-products (CBD Tinctures, Capsules & Softgels, CBD Gummies, Others) •By Application (Edibles and Fortified Foods, Workout Supplements, Wellness, Others) •By Distribution Channel (Retail Stores, Online, Pharmacies) |
Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
Company Profiles | Charlotte's Web, CV Sciences, Elixinol, Green Roads, Medterra, PureKana, HempFusion, Lazarus Naturals, Joy Organics, FAB CBD, Sunday Scaries, CBDFx, Koi CBD, cbdMD, Green Gorilla, NuLeaf Naturals, Serenity CBD, Vitality CBD, The CBDistillery, American Shaman, and other players. |
Key Drivers | •Increased consumer awareness of the need for natural wellness solutions propels CBD Nutraceuticals Market growth. •Increasing Legalization and Regulatory Support for CBD Products |
Restraints | •The advancement in the legalization of CBD products, this market remains extremely challenging due to the inconstant and very complex regulatory frameworks across the various regions. |
Ans- The CBD Nutraceuticals Market was valued at USD 9.57 billion in 2023 and is expected to reach USD 39.06 billion by 2032.
Ans – The CAGR rate of the CBD Nutraceuticals Market during 2024-2032 is 16.38%.
Ans- The CBD tinctures segment dominated the market by 40%
Ans- North America held the largest revenue share by 50%.
Ans- Asia Pacific is the fastest-growing region in the CBD Nutraceuticals Market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Production Capacity and Utilization Analysis by Region
5.2 Feedstock Prices Analysis by Region
5.3 Regulatory Impact: Effects of regulations on production and usage.
5.4 Environmental Metrics Analysis by Region
5.5 Consumer Demographics
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. CBD Nutraceuticals Market Segmentation, by Product Type
7.1 Chapter Overview
7.2 CBD tinctures
7.2.1 CBD tinctures Market Trends Analysis (2020-2032)
7.2.2 CBD tinctures Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Capsules & softgels
7.3.1 Capsules & softgels Market Trends Analysis (2020-2032)
7.3.2 Capsules & softgels Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 CBD gummies
7.4.1 CBD gummies Market Trends Analysis (2020-2032)
7.4.2 CBD gummies Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Others
7.5.1 Others Market Trends Analysis (2020-2032)
7.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. CBD Nutraceuticals Market Segmentation, by Application
8.1 Chapter Overview
8.2 Edibles and Fortified Foods
8.2.1 Edibles and Fortified Foods Market Trends Analysis (2020-2032)
8.2.2 Edibles and Fortified Foods Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Workout Supplements
8.3.1 Workout Supplements Market Trends Analysis (2020-2032)
8.3.2 Workout Supplements Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Wellness
8.4.1 Wellness Market Trends Analysis (2020-2032)
8.4.2 Wellness Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. CBD Nutraceuticals Market Segmentation, by Distribution Channel
9.1 Chapter Overview
9.2 Retail stores
9.2.1 Retail stores Market Trends Analysis (2020-2032)
9.2.2 Retail stores Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Online
9.3.1 Online Market Trends Analysis (2020-2032)
9.3.2 Online Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Pharmacies
9.4.1 Pharmacies Market Trends Analysis (2020-2032)
9.4.2 Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America CBD Nutraceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.4 North America CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.6.2 USA CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.7.2 Canada CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.8.2 Mexico CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe CBD Nutraceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe CBD Nutraceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.7.2 France CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.8.2 UK CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific CBD Nutraceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.6.2 China CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.7.2 India CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.8.2 Japan CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.9.2 South Korea CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.11.2 Singapore CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.12.2 Australia CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East CBD Nutraceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.4 Middle East CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa CBD Nutraceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.4 Africa CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America CBD Nutraceuticals Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.4 Latin America CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.6.2 Brazil CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.7.2 Argentina CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.8.2 Colombia CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America CBD Nutraceuticals Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America CBD Nutraceuticals Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America CBD Nutraceuticals Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
11. Company Profiles
11.1 Charlotte's Web
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 CV Sciences
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Green Roads
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Medterra
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 PureKana
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 HempFusion
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Lazarus Naturals
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Joy Organics
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 FAB CBD
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Sunday Scaries
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Product
CBD tinctures
Capsules & softgels
CBD gummies
Others
By Application
Edibles And Fortified Foods
Workout Supplements
Wellness
Others
By Distribution Channel
Retail stores
Online
Pharmacies
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization to meet the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Precision Diagnostics Market Size was valued at USD 75.87 Billion in 2023 and is expected to reach USD 224.53 Billion by 2032 and grow at a CAGR of 13.50% over the forecast period 2024-2032.
The Host Cell Protein Testing Market Size was valued at USD 2.15 Bn in 2023 and will reach USD 4.34 Bn by 2032 and grow at a CAGR of 8.14% by 2024-2031.
The Veterinary Therapeutics Market size was valued at USD 43.58 Billion in 2023 and is projected to reach USD 82.40 Billion By 2032, Growing at a CAGR of 7.35% from 2024 to 2032.
The Cancer Biologics Market Size was valued at USD 102.2 Billion in 2023 and is expected to reach USD 195.5 Bn by 2032, with a growing CAGR of 7.5% Over the Forecast Period of 2024-2032.
The Virtual Fitness Market size was estimated at USD 16.03 billion in 2023 and is expected to reach USD 151.35 billion by 2032 at a CAGR of 28.35% during the forecast period of 2024-2032.
The Neurorehabilitation Market was valued at USD 1.95 billion in 2023 and expected to reach USD 6.18 billion by 2032, at a CAGR of 13.68%.
Hi! Click one of our member below to chat on Phone